These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. TAK 044. Drugs R D; 1999 Jul; 2(1):35-7. PubMed ID: 10610279 [No Abstract] [Full Text] [Related]
7. Endothelin receptor blockade and exacerbation of heart failure. Szokodi I; Piuhola J; Ruskoaho H Circulation; 2003 Jun; 107(22):e211. PubMed ID: 12796421 [No Abstract] [Full Text] [Related]
8. J 104132. L 753037. Drugs R D; 1999 Jul; 2(1):26-7. PubMed ID: 10610293 [No Abstract] [Full Text] [Related]
9. The rise and fall of endothelin receptor antagonists in congestive heart failure. Handoko ML; de Man FS; Vonk-Noordegraaf A Eur Respir J; 2011 Mar; 37(3):484-5. PubMed ID: 21357921 [No Abstract] [Full Text] [Related]
10. [Pharmacological and clinical profile of a novel dual endothelin receptor antagonist, macitentan (Opsumit Takahashi S; Horie R; Yokoyama Y Nihon Yakurigaku Zasshi; 2017; 149(1):49-58. PubMed ID: 28049880 [No Abstract] [Full Text] [Related]
11. New developments in heart failure: role of endothelin and the use of endothelin receptor antagonists. Suresh DP; Lamba S; Abraham WT J Card Fail; 2000 Dec; 6(4):359-68. PubMed ID: 11145761 [TBL] [Abstract][Full Text] [Related]
14. Endothelin receptor antagonists. Promising new agents in the management of cardiovascular disorders. Goddard J; Webb DJ Drugs R D; 1999 Jul; 2(1):1-12. PubMed ID: 10560541 [TBL] [Abstract][Full Text] [Related]
15. Endothelin stimulates an endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine, in experimental heart failure. Ohnishi M; Wada A; Tsutamoto T; Fujii M; Matsumoto T; Yamamoto T; Takayama T; Wang X; Kinoshita M Clin Sci (Lond); 2002 Aug; 103 Suppl 48():241S-244S. PubMed ID: 12193095 [TBL] [Abstract][Full Text] [Related]
16. Pleiotropic effects of long-term monotherapy with rosuvastatin in dogs with moderate heart failure. Chello M; Spadaccio C Cardiology; 2013; 124(1):36-7. PubMed ID: 23295545 [No Abstract] [Full Text] [Related]
17. Dual Endothelin-A/Endothelin-B Receptor Blockade and Cardiac Remodeling in Heart Failure With Preserved Ejection Fraction. Valero-Munoz M; Li S; Wilson RM; Boldbaatar B; Iglarz M; Sam F Circ Heart Fail; 2016 Nov; 9(11):. PubMed ID: 27810862 [TBL] [Abstract][Full Text] [Related]
18. Clinical pharmacokinetics and pharmacodynamics of the endothelin receptor antagonist macitentan. Sidharta PN; Treiber A; Dingemanse J Clin Pharmacokinet; 2015 May; 54(5):457-71. PubMed ID: 25860376 [TBL] [Abstract][Full Text] [Related]